Hyaluronic acid production in Bacillus subtilis

Applied and Environmental Microbiology

Volumn 71, Issue 7, 2005, Pages 3747-3752

  Widner, Bill ^a   Behr, Régine ^a   Von Dollen, Steve ^a   Tang, Maria ^a   Heu, Tia ^a   Sloma, Alan ^a   Sternberg, Dave ^a   Deangelis, Paul L ^b   Weigel, Paul H ^b   Brown, Steve ^a  

^a Novozymes Biotech Inc   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES; GENES; POLYSACCHARIDES; SUGARS; SYNTHESIS (CHEMICAL);

ARTIFICIAL OPERONS; BACILLUS SUBTILIS; GENES ENCODING ENZYMES; HYALURONIC ACID (HA);

BACTERIA;

DNA; HYALURONIC ACID; PLASMID VECTOR; URIDINE DIPHOSPHATE GLUCURONIC ACID;

ENZYME; GENE EXPRESSION;

ARTICLE; BACILLUS SUBTILIS; BACTERIAL GENE; BACTERIAL GROWTH; ESCHERICHIA COLI; FERMENTATION; GCAD GENE; GTAB GENE; HASA GENE; HASB GENE; HASC GENE; HASD GENE; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PENTOSE PHOSPHATE CYCLE; POLYMERASE CHAIN REACTION; TUAD GENE;

BACILLUS SUBTILIS; BIOREACTORS; FERMENTATION; GLUCURONOSYLTRANSFERASE; HYALURONIC ACID; INDUSTRIAL MICROBIOLOGY; LABORATORIES; RECOMBINANT PROTEINS; STREPTOCOCCUS;

BACILLUS SUBTILIS; STREPTOCOCCUS DYSGALACTIAE SUBSP. EQUISIMILIS;

EID: 22144435605     PISSN: 00992240     EISSN: None     Source Type: Journal    
DOI: 10.1128/AEM.71.7.3747-3752.2005     Document Type: Article

References (48)

1. Adam, N., and P. Ghosh. 2001. Hyaluronan molecular weight and polydispersity in some commercial intra-articular injectable preparations and in synovial fluid. Inflamm. Res. 50:294-299.
2. Anagnostopoulos, C., and J. Spizizen. 1961. Requirements for transformation of Bacillus subtilis. J. Bacteriol. 81:741-746.
3. Balasz, E. A. February 1979. Ultrapure hyaluronic acid and use thereof. U.S. patent 4,141,973.
4. Bitter, T., and M. Muir. 1962. A modified uronic acid carbazole reaction. Anal. Biochem. 4:330-334.
5. Branner, S., S. Hastrup, N. Eriksen, P. Lindegaard, O. Olsen, E. Casteleijn, M. Egmond, J. Haverkamp, W. Musters, and J. de Vlieg. January 1996. Subtilisin mutants. U.S. patent 5,482,849.
6. Carter, G. R., and E. Annau. 1953. Isolation of capsular polysaccharides for colonial variants of Pasteurella multocida. Am. J. Vet. Res. 14:475-478.
7. Crater, D. L., and I. van de Rijn. 1995. Hyaluronic acid synthesis operon (has) expression in group A streptococci. J. Biol. Chem. 270:18452-18458.
8. DeAngelis, P. L., W. Jing, R. R. Drake, and A. M. Achyuthan. 1998. Identification and molecular cloning of a unique hyaluronan synthase from Pasteurella multocida. J. Biol. Chem. 273:8454-8458.
9. DeAngelis, P. L., W. Jing, M. V. Graves, D. E. Burbank, and J. L. Van Etten. 1997. Hyaluronan synthase of Chlorella virus PBCV-1. Science 278:1800-1803.
10. DeAngelis, P. L., J. Papaconstantinou, and P. H. Weigel. 1993. Molecular cloning, identification, and sequence of the hyaluronan synthase gene from group A Streptococcus pyogenes. J. Biol. Chem. 268:19181-19184.
11. Debabov, V. G. 1982. The industrial use of bacilli, p. 331-370. In D. A. Dubnau (ed.), Biology of the bacilli. John Wiley and Sons, New York, N.Y.
12. Goa, K. L., and P. Benfield. 1994. Hyaluronic acid: a review of its pharmacology and use as a surgical aid in ophthalmology and its therapeutic potential in joint disease and wound healing. Drugs 47:536-566.
13. Harwood, C. R. 1992. Bacillus subtilis and its relatives: molecular biological and industrial workhorses. Trends Biotechnol. 10:247-256.
14. Harwood, C. R., and S. M. Cutting (ed.). 1990. Molecular biological methods for Bacillus. John Wiley and Sons, Chichester, England.
15. Hascall, V. C., and T. C. Laurent. 1997. Hyaluronan: structure and physical properties. In V. C. Hascall and M. Yanagishita (ed.), Science of hyaluronan today. Seikagaku Corp., Tokyo, Japan. [Online.] www.GlycoForum.gr.jp.
16. Heldermon, C. D., P. L. DeAngelis, and P. H. Weigel. 2001. Topological organization of the hyaluronan synthase from Streptococcus pyogenes. J. Biol. Chem. 276:2037-2046.
17. Heldermon, C. D., V. L. Tlapak-Simmons, B. A. Baggenstoss, and P. H. Weigel. 2001. Site-directed mutation of conserved cysteine residues does not inactivate the Streptococcus pyogenes hyaluronan synthase. Glycobiology 11:1017-1024.
18. Itano, N., and K. Kimata. 1996. Expression cloning and molecular characterization of HAS protein, a eukaryotic hyaluronan synthase. J. Biol. Chem. 271:9875-9878.
19. Kendall, F. I., M. Heidelberger, and M. H. Dawson. 1937. A serologically inactive polysaccharide elaborated by mucoid strains of group A Streptococcus. J. Biol. Chem. 118:61-69.
20. Kim, J.-H., S.-J. Yoo, D.-K. Oh, Y.-G. Kweon, D.-W. Park, C.-H. Lee, and G.-H. Gil. 1996. Selection of a Streptococcus equi mutant and optimization of culture conditions for the production of high molecular weight hyaluronic acid. Enzyme Microbiol. Technol. 19:440-445.
21. Knudson, C. B., and W. Knudson. 1993. Hyaluronan-binding proteins in development, tissue homeostasis, and disease. FASEB J. 7:1233-1241.
22. Kumari, K., and P. H. Weigel. 1997. Molecular cloning, expression, and characterization of the authentic hyaluronan synthase from group C Streptococcus equisimilis. J. Biol. Chem. 272:32539-32546.
23. Kunst, F., et al. 1997. The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature 390:249-256.
24. Laurent, T. C., and J. R. E. Fraser. 1992. Hyaluronan. FASEB J. 6:2397-2404.
25. Maclennan, A. P. 1956. The production of capsules, hyaluronic acid and hyaluronidase by 25 strains of group C streptococci. J. Gen. Microbiol. 15:485-491.
26. Matsubara, C., M. Kajiwara, H. Akasaka, and S. Haze. 1991. Carbon-13 nuclear magnetic resonance studies on the biosynthesis of hyaluronic acid. Chem. Pharm. Bull. 39:2446-2448.
27. O'Regan, M., I. Martini, F. Crescenzi, C. DeLuca, and M. Lansing. 1994. Molecular mechanisms and genetics of hyaluronan biosynthesis. Int. J. Biol. Macromol. 16:283-286.
28. Perkins, J. B., A. Sloma, T. Hermann, K. Theriault, E. Zachgo, T. Erdenberger, N. Hannett, N. P. Chatterjee, V. Williams II, G. A. Rufo, Jr., R. Hatch, and J. Pero. 1999. Genetic engineering of Bacillus subtilis for the commercial production of riboflavin. J. Ind. Microbiol. Biotechnol. 22:8-18.
29. Pitcher, D. G., N. A. Saunders, and R. J. Owen. 1989. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett. Appl. Microbiol. 8:151-156.
30. Puttick, M. P., J. P. Wade, A. Chalmers, D. G. Connell, and K. K. Rangno. 1995. Acute local reactions after intraarticular hylan for osteoarthritis of the knee. J. Rheumatol. 22:1311-1314.
31. Sauer, U., D. C. Cameron, and J. E. Bailey. 1998. Metabolic capacity of Bacillus subtilis for the production of purine nudeosides, riboflavin, and folic acid. Biotechnol. Bioeng. 59:227-238.
32. Shyjan, A. M., P. Heldin, E. C. Butcher, T. Yoshino, and M. J. Briskin. 1996. Functional cloning of the cDNA for a human hyaluronan synthase. J. Biol. Chem. 271:23395-23399.
33. Sloma, A., and L. Christianson. April 1999. Nucleic acids encoding a polypeptide having protease activity. U.S. patent 5,891,701.
34. Sloma, A., R. Behr, W. Widner, M. Tang, D. Sternberg, and S. Brown. 2003. Methods for producing hyaluronan in a recombinant host cell. World patent application WO03/054163.
35. Soldo, B., V. Lazarevic, M. Pagni, and D. Karamata. 1999. Teichuronic acid operon of Bacillus subtilis 168. Mol. Microbiol. 31:795-805.
36. Spicer, A. P., M. L. Augustine, and J. A. McDonald. 1996. Molecular cloning and characterization of a putative mouse hyaluronan synthase. J. Biol. Chem. 271:23400-23406.
37. Swann, D. A., and J.-W. Kuo. 1991. Hyaluronic acid, p. 286-305. In D. Byrom (ed.), Biomaterials-novel materials from biological sources. Stockton Press, New York, N.Y.
38. Tlapak-Simmons, V. L., B. A. Baggenstoss, T. Clyne, and P. H. Weigel. 1999. Purification and lipid dependence of the recombinant hyaluronan synthases from Streptococcus pyogenes and Streptococcus equisimilis. J. Biol. Chem. 274:4239-4245.
39. Toole, B. P. 1991. Proteoglycans and hyaluronan in morphogenesis and differentiation, p. 305-341. In E. D. Hay (ed.), Cell biology of the extracellular matrix. Plenum Press, New York, N.Y.
40. Townsend, K. M., J. D. Boyce, J. Y. Chung, A. J. Frost, and B. Adler. 2001. Genetic organization of Pasteurella multocida cap loci and development of a multiplex capsular PCR typing system. J. Clin. Microbiol. 39:924-929.
41. Ward, P. N., T. R. Field, W. G. F. Ditcham, E. Maguin, and J. Leigh. 2001. Identification and disruption of two discrete loci encoding hyaluronic acid capsule biosynthesis genes hasA, hasB, and hasC in Streptococcus uberis. Infect. Immun. 69:392-399.
42. Watanabe, K., and Y. Yamaguchi. 1996. Molecular identification of a putative human hyaluronan synthase. J. Biol. Chem. 271:22945-22948.
43. Weigel, P. H. 2002. Functional characteristics and catalytic mechanisms of the bacterial hyaluronan synthases. IUBMB Life 54:201-211.
44. Weissman, B., and K. Myer. 1954. The structure of hyalbiuronic acid and hyaluronic acid from umbilical cord. J. Am. Chem. Soc. 76:1753-1757.
45. Widner, W., M. Thomas, and A. Sloma. September 1999. Methods for producing a polypeptide in a Bacillus cell. U.S. patent 5,955,310.
46. Widner, B., M. Thomas, D. Sternberg, D. Lammon, R. Behr, and A. Sloma. 2000. Development of marker-free strains of Bacillus subtilis capable of secreting high levels of industrial enzymes. J. Ind. Microbiol. Biotechnol. 25:204-212.
47. Wohlrab, W., and N. Reinhard. 2000. Skin protection agents containing a fragment mixture produced from hyaluronic acid by hydrolysis. World patent application WO00/38647.
48. Wyatt, P. J. 1997. Multiangle light scattering combined with HPLC. LCGC 15:160-168.